- $4.64m
- $3.22m
- $5.72m
Brief: Callan Jmb Complaint Filed By Eddie Patent Holdings Does Not Impact Operations, Strategic Partnerships, Or Ongoing Projects
NASDAQ RESUMED AT 10:41 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:36 AM
NASDAQ RESUMED AT 10:00 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:55 AM
NASDAQ RESUMED AT 09:38 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:33 AM
Brief: Callan JMB Signs Manufacturing Oversight, Federal Deployment, And Commercialization Agreement Of Multi-Asset Therapeutic Pipeline With Attune For Approximately $50 To $75 Million In Total Revenue
Brief: Callan Jmb Inc Files For Resale Of 6,000,000 Shares Of Common Stock
Brief: Callan JMB Inc - Enters Agreement To Sell Up To $25 Million In Shares - SEC Filing
Brief: Callan JMB Inc As Of May 13, Terminates CFO Jeffrey Appleman Effective Immediately
Brief: Callan JMB Receives Request From The State Of Texas Department Of Health And Human Services To Be On Standby In Response To Measles Outbreak
Brief: Callan JMB Announces Closing Of $5.12 Million Initial Public Offering